KOD
KOD
NASDAQ · Biotechnology

Kodiak Sciences Inc

$22.75
+0.90 (+4.12%)
As of Mar 25, 10:01 PM ET ·
Financial Highlights (FY 2025)
Revenue
639.02M
Net Income
3.07M
Gross Margin
30.9%
Profit Margin
0.5%
Rev Growth
+2.1%
D/E Ratio
0.55
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 30.9% 30.9% 30.9%
Operating Margin 0.6% 0.5% 0.5%
Profit Margin 0.5% 0.5% 0.4%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 639.02M 671.15M 526.83M
Gross Profit 197.59M 207.53M 162.90M
Operating Income 3.52M 3.36M 2.88M
Net Income 3.07M 3.06M 2.31M
Gross Margin 30.9% 30.9% 30.9%
Operating Margin 0.6% 0.5% 0.5%
Profit Margin 0.5% 0.5% 0.4%
Rev Growth +2.1% +18.5% -6.0%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 226.42M 203.30M 203.61M
Total Equity 412.58M 456.58M 416.75M
D/E Ratio 0.55 0.45 0.49
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 3.98M 4.67M 3.27M
Free Cash Flow 2.86M 3.84M 2.49M